Edgar Wachenheim III
Greenhaven Associates
Edgar Wachenheim III NOV Inc stake
total: 102
Greenhaven Associates NOV trades
- Total transactions:
- 11
- New positions:
- 1
- Added:
- 8
- Reduced:
- 2
- Held since:
- 2023 Q3
- Held for:
- 12 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Edgar Wachenheim III holds 5,620,019 NOV Inc (NOV) shares with a market value of roughly $104.25M accounting for 1.20% of the overall portfolio. To date, the estimated cost basis is nearly $16.16 for "buy" trades and estimated average "sell" price is $18.5. Greenhaven Associates first purchased NOV in 2023 Q3, initially acquiring about 1.56M shares. Since the initial investment in NOV Inc (NOV), Greenhaven Associates has made 10 more transactions.
When did Edgar Wachenheim III buy NOV Inc (NOV)?
Edgar Wachenheim III first invested in NOV Inc (NOV) in 2023 Q3 at the reported quarter-end price of $20.90 per share.
What's the cost basis of Greenhaven Associates's NOV stake?
The estimated cost basis for NOV Inc (NOV) stake is around $16.16 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $16.16
- Weighted AVG sell price:
- $18.50
Edgar Wachenheim III's historical trades in NOV Inc
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
1.20%
|
5,620,019
|
$18.55
|
$104,251,352
|
-2.28% (-131,319)
|
-0.04%
|
|
2026 Q1
|
1.78%
|
5,751,338
|
$18.81
|
$108,182,668
|
+0.11% (+6,200)
|
+0%
|
|
2025 Q4
|
1.46%
|
5,745,138
|
$15.63
|
$89,796,507
|
-0.04% (-2,544)
|
-0%
|
|
2025 Q3
|
1.16%
|
5,747,682
|
$13.25
|
$76,156,787
|
+15.36% (+765,166)
|
+0.15%
|
|
2025 Q2
|
0.92%
|
4,982,516
|
$12.43
|
$61,932,674
|
+21.11% (+868,359)
|
+0.16%
|
|
2025 Q1
|
0.99%
|
4,114,157
|
$15.22
|
$62,617,470
|
+25.01% (+823,115)
|
+0.2%
|
|
2024 Q4
|
0.71%
|
3,291,042
|
$14.60
|
$48,049,213
|
+61.69% (+1,255,666)
|
+0.27%
|
|
2024 Q3
|
0.38%
|
2,035,376
|
$15.97
|
$32,504,955
|
+13.14% (+236,400)
|
+0.04%
|
|
2024 Q1
|
0.32%
|
1,798,976
|
$19.52
|
$35,116,012
|
+13.11% (+208,576)
|
+0.04%
|
|
2023 Q4
|
0.34%
|
1,590,400
|
$20.28
|
$32,253,312
|
+1.82% (+28,500)
|
+0.01%
|
|
2023 Q3
|
0.42%
|
$20.90
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.